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RESEARCH ARTICLELong-Term Retinal Differentiation of Human Induced
Pluripotent Stem Cells in a Continuously Perfused
Microfluidic Culture DeviceNima Abdolvand, Rui Tostoes, William Raimes, Vijay Kumar, Nicolas Szita,
and Farlan Veraitch*Understanding how microenvironmental cues influence cellular behavior will
enable development of efficient and robust pluripotent stem cell differentiation
protocols. Unlike traditional cell culture dishes, microfluidic bioreactors can
provide stable microenvironmental conditions by continuous medium perfusion
at a controlled rate. The aim of this study is to investigate whether a
microfluidic culture device could be used as a perfused platform for long-term
cell culture processes such as the retinal differentiation of human induced
pluripotent stem cells. The perfusion flow rate is established based on the
degradation and consumption of growth factors (DKK-1, Noggin, IGF-1, and
bFGF) and utilizing the Peclet number. The device’s performance analyzed by
qRT-PCR show improvements compared to the well-plate control as character-
ized by significantly higher expression of the markers Pax6, Chx10, and Crx on
Day 5, Nrl on day 10, Crx, and Rhodopsin on day 21. Optimization of perfusion
rate is an important operating variable in development of robust processes for
differentiation cultures. Result demonstrates convective delivery of nutrients via
perfusion has a significant impact upon the expression of key retinal markers.
This study is the first continuously perfused long-term (21 days) retinal
differentiation of hiPSCs in a microfluidic device.1. Introduction
In 2006, Maclaren et al. demonstrated that postnatal post-
mitotic photoreceptor precursors can successfully integrate
into mice retina and form functional photoreceptors.[1] Since
then, there has been considerable efforts to develop retinal
differentiation protocols from pluripotent stem cells (PSCs).[2–
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crucial when it comes to increasing
integration efﬁciency into the host ret-
ina.[12–18] Optimizing the conditions with
which PSCs undergo retinal differentia-
tion will be critical to improving the
robustness, consistency, and efﬁcacy of
photoreceptor cell therapies.[19–21]
Retinal differentiation protocols for both
human embryonic stem cells (hESCs) and
human induced pluripotent stem cells
(hiPSCs) have been developed in tradi-
tional culture formats such as T-ﬂasks and
well-plates. These formats lack the micro-
environmental controls required to main-
tain stable culture conditions. Daily
medium replacements result in ﬂuctua-
tions in pH, metabolites and growth
factors. These short-term variations do
not accurately represent the in vivo envi-
ronment present during embryonic devel-
opment and can adversely affect the
expansion and differentiation of ESCs.[22]
One solution is the adoption of perfusion
bioreactors that can maintain constant
concentrations of soluble factors in the
liquid growth medium.[23,24]Microﬂuidic devices have a number of advantages including
ﬁne spatiotemporal control over the ﬂuid ﬂow, small culture
chambers, and the potential to run many bioreactors in
parallel.[25,26] These properties make them a promising
platform for investigating the best conditions for stem cell
differentiation.
There are number of examples in which bespoke microﬂuidic
culture devices have been used to study 2D differentiation
processes. These include angiogenesis of mesenchymal stem
cells,[27] differentiation of hESCs and hiPSCs toward meso-
dermal and extra-embryonic trophoblast lineage, respec-
tively.[28,29] Others demonstrated successful culture of
pluripotent stem cells under stable culture conditions[30] and
long-term differentiation cultures such as, myotube differentia-
tion of myoblasts and role of auto/paracrine factors on
adipogenic differentiation of adipose-derived stem cells.[31,32]
Previously, we have developed a microﬂuidic culture device
(MFCD) that facilitates perfused culture of standard 2D culture
protocols.[33] A resalable lid allows direct manual inoculation ofnal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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seeding clumps of PSCs. This is especially important during
directed differentiation protocols, the majority of which rely
upon seeding aggregates of PSCs (known as embryoid bodies,
EBs) onto 2D surfaces for extended periods with complete
medium exchanges every 1-2 days. The device can be multi-
plexed and conﬁgured for non-invasive real-time measurements
of conﬂuency and oxygen uptake.[34,35]
The objective of this study was to investigate whether our
microﬂuidic chamber could be applied to long-term continu-
ously perfused cultures using retinal differentiation of hiPSCs as
a case study. We used a well characterized protocol[3] and
perfusion rates were decided based upon the consumption,
production, and diffusion rates of four key growth factors used to
induce differentiation. The onset of differentiation was moni-
tored via the expression of key early and late stage markers
revealing for the ﬁrst time that a perfused microﬂuidic device
could be used to drive the retinal differentiation of PSC. The
process closely mimicked traditional well plate culture, but
further investigation revealed that the perfusion rate could have
a marked impact upon the expression of phenotypic markers.2. Experimental Section
2.1. Human Induced Pluripotent Stem Cell Culture
The hiPSC line MSUH001 was obtained from Michigan State
University. The cell line had been created by reprogramming
the foetal female ﬁbroblast line IMR90 via lentiviral vectors
encoding the reprogramming factors Oct4, Sox2, Nanog, and
Lin28. Undifferentiated hiPSCs between passage number 68
and 78 were grown on Mitomycin-C (1mgmL1; Sigma-
Aldrich) inactivated mouse embryo ﬁbroblasts (MEF) in
Knockout DMEM supplemented with 20% (v/v) Knockout
Serum Replacement (KOSR), 1mM L-glutamine, 1% (v/v)
nonessential amino acids, 100mM β-mercaptoethanol, and
4 ngmL1 basic ﬁbroblast growth factor (all Invitrogen). They
were cultured in a Sanyo IncuSafe incubator at 37 C, and 5%
(v/v) CO2, and 10mL of fresh medium was exchanged every
48 h. hiPSCs were transferred to newly Mitomycin-C inacti-
vated MEF every 3–4 days with Fine Tip Mini Pastette (Alpha
Laboratories).2.2. Retinal Differentiation Protocol
2.2.1. EB Formation
Undifferentiated hiPSCs were used to form uniform size EBs of
1000 cells per EB according to the AggreWell 400TM protocol.
EB formation medium was prepared using DMEM/F-12
Medium (1:1) (GIBCOTM, ThermoFisher Scientiﬁc, USA),
10% (v/v) KOSR (Invitrogen, USA), 1 ngmL1 Dkk-1, 1 ngmL1
Noggin, 5 ngmL1 IGF-1 (all R&D Systems, Minneapolis, USA),
1% (v/v) N-2 Supplement (PAA Laboratories Ltd., UK).
Undifferentiated hiPSCs were detached from T-25 ﬂasks using
Tryple Express (TrypLE, ThermoFisher Scientiﬁc) and sus-
pended as single cells in 50mL conical tubes through a 40 μmBiotechnol. J. 2018, 1800323 1800323 (2 of 13) © 2018 Thecell strainer (STEMCELL Technologies) to remove clumps.
Flasks were rinsed with 5mL of EB medium per millilitre of
TrypLE used and were centrifuged at 300 g for 5min at room
temperature. The supernatant was removed and the pellet
suspended in a small volume (1-2mL) of EB formation medium
with ROCK inhibitor (ROCKi, Y-27632). Cells were seeded at
1.2 106 cellsmL1 in to each well of the AggreWell plate and
incubated at 37 C, and 5% (v/v) CO2. After 24 h, spent medium
was exchanged for fresh medium without ROCKi and the EBs
were transferred to 30mm non-adherent bacterial grade culture
dishes (Sterilin) and cultured as cell suspensions for 2 more
days.2.2.2. Retinal Differentiation in Well Plates
48-well plates were used as controls for the perfusion studies.
Plates were coated with 250 μL of Matrigel (2%, BD Bioscience,
San Diego, CA, USA) for 15min and 7 EBs were transferred to
each well under a dissecting microscope. The retinal differenti-
ation medium contained DMEM/F12 (Invitrogen, US) supple-
mented with 10 ngmL1 human recombinant DKK-1,
10 ngmL1 human recombinant IGF-1, 10 ngmL1 human
recombinant Noggin, 5 ngmL1 basic ﬁbroblast growth factor
(all R&D Systems, Minneapolis, USA), 1% (v/v) N-2 Supple-
ment, and 2% (v/v) B27 Supplement (PAA Laboratories Ltd, UK).
The operating volume was 250 μL and spent medium was
replaced once every 48 h for the duration of the differentiation
protocol.2.2.3. Retinal Differentiation in Microfluidic Culture Device
(MFCD)
Each MFCD was inoculated with 7 EBs and incubated overnight
to allow EBs to attach to the culture surface before starting
medium perfusion. Two identical MFCDs were run in parallel
during the perfusion studies, one perfusing at 130 μL h1
(MFCDHi) and the other at 5.2 μL h
1 (MFCDLo). The lower ﬂow
rate was chosen as a control to mimic the frequency of medium
change in the static 48-well plates (i.e., 250 μL per 48 h and
medium height of 2.3mm). The medium height in the MFCDLo
was adjusted by using a shallower gas permeable lid that
provided a height of 2.28mm in the culture chamber. This height
adjustment allowed the ﬁne tuning of the MFCD to as closely
mimic the static control environment as possible in terms of
medium exchange rate. In both perfused devices and the control
culture, hiPSCs of the same batch and passage number were
used at each experimental replicate.2.3. Growth Factor Studies
12-well plates were used to study the degradation of DKK1,
bFGF, IGF-1 and noggin at 37 C in differentiation medium.
Plates were also inoculated with 30 EBs/well to investigate the
impact of cellular consumption and production of growth
factors. Where speciﬁed the medium was changed after 48 h as
was described in the retinal differentiation process in well platesAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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without cells were included to establish the degradation rates in
differentiation medium at 37 C. The changes in concentration
of all four growth factors during the ﬁrst 96 h of the EB
differentiation process were investigated by taking measure-
ments in the presence and absence of a full medium change at
48 h to observe how a scheduled medium change would affect
the growth factor levels over a ﬁxed period.2.4. ELISA
Medium samples were analyzed using sandwich ELISA kits for
bFGF, IGF-1, DKK-1 (Abcam ELISA kits, Cambridge, UK) and
Noggin ELISA kit (MyBioSource plc, San Diego, CA, USA). After
medium collection, the cells were harvested and counted using an
automatedVi-CELLCell Viability Analyser (BeckmanCoulter, Brea,
CA). Each ELISA assay was preformed according to the suppliers’
protocol and the plates were read at 450nm using a FLUOstar
OPTIMA (BMG LABTECH GmbH, Germany) microplate reader.2.5. Microfluidic Culture Device Fabrication and Assembly
The microﬂuidic perfusion culture device was based on
previously published designs.[33,35] In addition to the previously
described design, an aluminium frame was placed around each
of the two inter-connects to reinforce the top plate in order to
prevent liquid from leaking (Figure 1A–D).
Connections were made using autoclavable tubing with an
internal diameter (ID) of 0.8mm and outer diameter (OD) of
1.6mm (R1230, Upchurch Scientiﬁc, USA), along with ﬂange-
less M6 nuts (P-207, Upchurch Scientiﬁc, USA), female M6 to
male Luer lock adapters (P-660, Upchurch Scientiﬁc, USA) and
three-way stopcock (721664, Harvard Apparatus, UK). Syringe
pumps used were KD Scientiﬁc 100 pumpwith 20mL BD Plastic
syringe for 130 μL h1 perfusion runs and KD Scientiﬁc, Legato
212 with 2.5mL HSW Norm-Ject syringes for 5.2 μL h1
perfusion runs.2.6. Determination of Perfusion Rate
Based on the work of Mehta et al. in 2D modeling of
microchannels, dimensionless ratio Pe/α (Equation (1)) has a
determining effect in distribution of concentration in the culture
area.[36] Pe is the ratio of convective transfer of a species to its
diffusive transfer and it can be used to estimate whether a
particular species is being carried primarily by convection or
diffusion across the chamber. Pe/α value >1 denotes the species
of interest is delivered predominately through convection (i.e.,
ﬂuid ﬂow). In this way, Equation (1) can be used to create a quasi-
steady-state concentration (excluding cell-related consumption
or production) for the desired species in the culture chamber.
Pe
α
¼ Uh
2
DeL
ð1ÞBiotechnol. J. 2018, 1800323 1800323 (3 of 13) © 2018 TheU is the ﬂow velocity, h is the channel height, De is diffusion
coefﬁcient of the species, and L is the channel length, α is the
geometric ratio (L/h). The molecular weights of the growth
factors of interest have been reported as Noggin (46 kDa), DKK-1
(25.8 kDa), IGF-1 (7.5 kDa), and bFGF (17.4 kDa). In order to
estimate the diffusion coefﬁcients of these molecules, ﬂuores-
cently labelled dextrans of known molecular masses (10, 20, and
40 kDa) were used to calculate the Pe/α ratios (Table S1,
Supporting Information).2.7. Immunocytochemistry
Cells were ﬁxed with 2mL 4% (w/v) paraformaldehyde (PFA)
for 20min at room temperature and then permeabilized with
0.3% (v/v) Triton X-100 in Dulbecco’s modiﬁed phosphate-
buffered saline (PBS) for 10min at room temperature (all
from Sigma-Aldrich). Samples were washed with 2mL PBS
and incubated in a blocking solution consisting of 5% (v/v)
foetal bovine serum (FBS) diluted in PBS for 30min at room
temperature. Samples were incubated overnight at 4 C with
primary antibodies. The primary antibodies were all used at a
dilution of 1:200. Each sample was washed with 2mL of PBS
and incubated with secondary antibody solution at room
temperature for 1 hr (diluted at 1:400). Cells were washed
twice with PBS before adding a solution of 4,6-diamidino-2-
phenylindole (DAPI; Invitrogen; diluted at 1:1,000) and
incubated for 5min at room temperature before one ﬁnal
wash with PBS. Fluorescent images were acquired using
Nikon’s Eclipse TE2000-U and Life Technologies’ EVOS1 FL
ﬂuorescence microscopes. Complete list of primary and
secondary antibodies used provided in Table S2, Supporting
Information.2.8. Quantitative RT-PCR
2.8.1. RNA Extraction
RNAs were extracted using the Qiagen RNeasy kit (Qiagen,
Crawley, UK) as directed by manufacturer’s protocol. The RNA
concentration was determined by measuring absorbance at
260 nm, by spectrophotometer (NanoDrop ND-1000, Thermo
Scientiﬁc, Epson, UK).2.8.2. cDNA Synthesis
The concentration of each RNA sample was normalized to
undifferentiated hiPSC before synthesising cDNA using the
QuantiTect Whole Transcriptome Kit (Qiagen, Crawley, UK).
Ampliﬁed cDNAs were stored at 20 C before use in the next
step.2.8.3. qPCR
Quantitative polymerase chain reactions (qPCRs) were
performed by using the MESA BLUE qPCR MasterMix PlusAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Figure 1. A) Exploded view of the microfluidic culture device. B) Microfluidic chip, inlet and outlet channels, culture chamber, and their dimensions. C)
Image of the assembledmicrofluidic culture device with aluminium frames. D) Schematic representation of the perfusion set-up with syringe pump kept
outside of the incubator. E) Process timeline from hiPSCs culture to end-point analysis of the cells. The upper side of the line includes the specific steps,
and the lower side shows the timing of each process. F) Schematics representation of each process step. The stepwise process of retinal differentiation
was initiated by formation of the EBs using AggreWell 400TM, followed by a 2-day culture of the EBs with gentle shaking in low adherent bacterial dish. 7
EBs were transferred into one well of 48-well plate and culture area of eachMFCD coated with Matrigel for the retinal determination step. Following a 24-
h static incubation for attachment of the cells to the culture area the perfusion cultures were initiated at two flow rates of 130 and 5.2 μL h1, respectively.
The lower flow rate of 5.2 μL h1 provides similar medium height and identical medium exchange to the 48-well plate control, providing a second control
for the MFCD with the higher flow rate. Expression of the retinal markers was analyzed using immunocytochemistry and qPCR.
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manufacturer’s instructions. Primer pairs for the target and
housekeeping genes, β-actin, UBC, Oct4, Sox2, Nanog,
Nesting, Sox17, Brachyury, Otx2, Pax6, Lhx2, Six6, Vsx2/
Chx10, Crx, Nrl and Rhodopsin were all aquired from Qiagen
(Qiagen, Germany, Table S3, Supporting Information).
Triplicates were run for each sample and all samples were
normalized to levels of β-actin and UBC expression in hiPSCs.
hiPSCs were used to act as a calibrator between the time
points.2.9. Statistical Analysis
All cell culture experiments were conducted as biological
triplicates (n¼ 3). Data points are presented as the mean of
three repeats, and error bars represent SEM. p< 0.05 was
considered to be signiﬁcant, indicated in the ﬁgures by an
asterisk (). When comparingmeans of two paired groups, a two-
tailed, paired t-test was used. In order to ﬁnd signiﬁcant
differences of gene expression between ﬂow rates and the
control, a one-way repeated ANOVA was used followed by
Tukey’s post-hoc multiple comparisons test.3. Results
3.1. Characteristics of the Microfluidic Culture Device
The modular design of the MFCD was comprised of a gas
permeable lid made from poly(dimethylsiloxane) (PDMS) and a
lid holder from polycarbonate (PC), two interconnects made of
PC, a top frame (PC), bottom frame and reinforcement brackets
made from Aluminium (Al), a gasket and a microﬂuidic chip
made fromPDMS, and a tissue-culture polystyrene (TC-PS) slide
as a culture surface, mirroring the same culture surface as
conventional cell culture dishes. The cassette-like design allowed
for replacement of the individual parts when necessary, reducing
time and fabrication costs compared to single-use devices. All
parts were autoclavable, and gas permeable parts allowed
sufﬁcient aeration to the culture chamber. The MFCD was
primed by circulating the media via three-way valves through the
inlet and outlet of the device to remove any trapped bubbles prior
to seeding the EBs. The fresh media was perfused through the
device via a syringe connected to a syringe pump placed outside
the incubator and kept on ice-packs for the duration of the
experiments (Figure 1D). The microﬂuidic chip was designed
such that housed a 0.52 cm2 culture area providing a uniform
ﬂow by use of 200 μm deep ﬂow channels connecting the inlet
and outlet ports to the culture chamber. Furthermore, it provided
a very low mean hydrodynamic shear stress of 1.33104 Pa
 0.37104 Pa (calculated by computational ﬂuid dynamics
modelling) at the height of 10mm above the culture surface at a
ﬂow rate of 300mLh1.[33] This avoids adverse effects of the
hydrodynamic shear stress on cellular processes, making it an
ideal device for the study of convective delivery of nutrients on
differentiation cultures. Figure 1E,F shows the process ﬂow
chart for the retinal differentiation of hiPSCs in our microﬂuidic
device.Biotechnol. J. 2018, 1800323 1800323 (5 of 13) © 2018 The3.2. Growth Factor’s Dynamics During Retinal
Differentiation of hiPSCs
The degradation, consumption, and production of the four key
growth factors involved in the retinal differentiation process of
hiPSCs were investigated in order to establish a perfusion rate
for the differentiation process.
During cell-free experiments DKK-1 was shown to degrade
most rapidly and was reduced to only 48% of its initial
concentration in an 8h period (Figure 2A). There was also
degradation of bFGF and Noggin (Figure 2B,C) resulting in
concentration drops of 69 and 46%, respectively, relative to their
initial concentrations, within the ﬁrst 24 h. IGF-1 was stable at
37 C (Figure 2D).
In the presence of differentiating hiPSCs DKK-1 levels
dropped rapidly from 5.27 0.23 ngmL1 to 2.53 0.25 ng
mL1 within the ﬁrst 8 h (Figure 2A). DKK-1 concentration
decreased a further 12% between 8 and 24 h where it remained
steady before themedium exchange at 48 h. After exchanging the
medium, the decrease in concentration followed a similar trend.
However, there was a clear increase in DKK-1 concentration
between 72 and 96 h post medium change indicating that the
cells may have started secreting the growth factor during this
later period (Figure S1, Supporting Information).
The concentration of bFGF remained high in cultures at
4.23 0.71 ngmL1 for both with and without medium
exchange (Figure 2B). Since degradation studies showed
degradation of bFGF by 69% within the ﬁrst 24 h, we concluded
that the cells were producing bFGF (Figure S1B, Supporting
Information).
Noggin and IGF-1 concentrations decreased during the ﬁrst
24 h from 4.84 0.24 and 6.56 0.35 ngmL down to 0.82 0.41
and 3.53 0.29 ngmL1, respectively, before remaining steady
until the medium change at 48 h (Figure 2C,D). After the
medium change the concentration of both growth factors
dropped rapidly within the ﬁrst 4 h before then plateauing for the
remainder of the culture period.3.3. Determination of Perfusion Rate for Convective
Delivery of Nutrients
The ratio Pe/α was used to determine the minimum ﬂow rate
required for delivering growth factors of interest in retinal
differentiation medium. Figure 2E shows that a ﬂow rate of
650 μL h1 is required to have bFGF, Noggin, and DKK-1 in
primarily convective delivery. A ﬂow rate of 130 μL h1 is
required to have DKK-1 and Noggin in convection and
100 μL h1 for only Noggin to be in predominately convective
ﬂow. IGF-1 has a molecular weight of 7.5 kDa, which requires a
ﬂow rate of more than 650 μL h1 to be delivered to the cells by
convection. Based on the high degradation rate of DKK-1, the
high consumption rate of Noggin and the importance of both
growth factors as conﬁrmed in an independent study[5] we
decided to use a ﬂow rate of 130 μLh1. At this ﬂow rate both of
these key growth factors would be delivered to the cells via
convection maintaining a steady concentration as the cells
differentiate.Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Device
In order to conﬁrm that a perfusion rate of 130 μL h1 was
sufﬁcient to deliver constant concentrations of themost unstable
growth factors we measured the concentration of DKK-1 (MW
25.8 kDa) at the inlet and outlet of the MFCD (Figure 2F). EBs
were formed via centrifugation using AggreWell 400TM plates
and allowed to mature in suspension before being seeded
directly into the microﬂuidic chamber. Once inoculated the
device was run in static mode for 24 h to allow the EBs to attach
before switching to perfusion mode.
During the differentiation process in the 48-well plate control,
the concentration of DKK-1 ﬂuctuated from initial concentration
of 5.51 0.81 ngmL down to 0.47 0.24, 2.48 0.16, and
4.14 0.73 ngmL at 48, 96, and 144 h, corresponding to the
complete medium changes which were performed every 48 h.
These ﬂuctuations became less and less pronounced reaching to
values of 4.90 0.64 and 4.91 0.83 ngmL as the differentiation
process progressed until day 10. In the continuously perfused
MFCD there was a signiﬁcant (p< 0.001) drop in DKK-1 when
comparing the inlet and outlet concentrations at 24 and 48 h.
This implies that cells were indeed consuming DKK-1 as it
passed through the chamber. The DKK-1 concentration in the
MFCD at the outlet shows a 45% reduction in concentration of
this factor within the ﬁrst 48 h of perfused culture as compared
with a 90% drop in 48-well plates.3.5. Morphological Analysis of the Cultures During Retinal
Differentiation
In subsequent differentiation experiments the microﬂuidic
device was perfused at two ﬂow rates. 130 μLh1 (MFCDHi) and
a lower ﬂow rate of 5.2 μL h1 (MFCDLo) were run in parallel to
investigate whether the process was improved by lower ﬂow rates
which may allow the accumulation of secreted factors.
The initial 24 h incubation in static prior to starting perfusion
allowed EBs to partially expand and adhere to the surface. During
this period EBs maintained their 3D structure where gradual
spreading of the cells outward from the core of the EBs formed a
unicellular layer on the periphery and a dense multi-layered core
during the ﬁrst 4-5 days in all cases (Figure 3A,C). There was no
morphological evidence on reaction of the cells to the perfusion
during the course of experiments. Multi-layered structures
formed throughout the culture period in all three conditions.
Neural rosettes appeared between days 5–6 in the 48-well plates
controls and disappearing on day 8–9. The rosettes were not
observed in the MFCDHi (Figure 3D–F). In the MFCDLo the
neural rosettes had a delayed appearance compared to the 48-
well plates control. They were observed on days 8–9, and stayed
for a longer period before disappearing between days 12–14
(Figure 3M–R). In the 48-well plate controls, EBs tended to
aggregate in the centre of the culture area, creating a denser
population in the middle before spreading throughout the
culture area (Figure 3G).
In the MFCDHi uniform expansion was observed with fewer
3D like structures. The EBs expanded inmonolayers early duringBiotechnol. J. 2018, 1800323 1800323 (7 of 13) © 2018 Thedifferentiation before growing into multi-layers later on. After
day 10, cells exhibited a higher degree of homogeneity compared
to the other cultures (Figure 3C, F, I, L) In theMFCDHi, sheets of
hexagonal cells morphologicaly similar to early RPE cells,
(without any pigmentation commonly observed inmature RPEs)
were observed between days 10 and 12 (Figure 3K). These
cellular layers disappeared after a period of 4–5 days.3.6. Expression of the Retinal Progenitor Markers
In order to investigate whether the differentiation was occurring,
MFCD and control cultures were stained for a panel of retinal
lineage markers. Both perfused cultures as well as the static
control culture exhibited positive expression of early neuro-
ectoderm markers, Nestin and Otx2 after 5 days. After 10 days,
the expression of eye-ﬁeld transcription factor (EFTF), Pax6, and
optic vesicle (OV) marker, Vsx2/Chx10, was observed across all
culture formats. Expression of photoreceptor precursors
markers, Crx and Nrl were observed on day 21 of culture
(Figure 4A,C).3.7. Improved Gene Expression in Perfused Cultures
qPCR was undertaken to study the effect of the MCFD and ﬂow
rate on the expression of pluripotency, retinal, and germ layer
markers. The ﬁrst 5 days of culture revealed an expected
downregulation of pluripotency markers Oct4, Nanog, and Sox2
as cells began to differentiate. As differentiation progressed
there was continued downregulation of Oct4 and Nanog with no
signiﬁcant differences between the MCFDs and 48-well plate
controls (Figure 5A,B). After an initial downregulation of Sox2
expression, a rise was evident in all cultures apart from the
MFCDLo after day 5 (Figure 5C).
Figure 5D Shows upregulation of Nestin (ectoderm) during
the course of differentiation across devices. There was no
signiﬁcant difference between different culture formats.
Expression of an early mesoderm (Brachyury) and an early
endoderm (Sox17) markers were investigated to determine the
extent to which the differentiation in the MCFD would be
directed into lineages not capable of differentiating into neural
retinal cells. There was a small increase in the expression of both
genes during the ﬁrst 5 days in all three conditions after which
they were downregulated. After 21 days of differentiation the
highest expression of Brachyury was in the MFCDHi while the
highest expression of Sox17 was observed in the MFCDLo
(Figure 5E,F).
In terms of early retinal marker expression, the expression of
Otx2 increased most rapidly between day 5 and 10 in the 48-well
plate control (Figure 5G). On day 5, Pax6 expression was highest
in the MFCDLo (p< 0.05). On day 21, Pax6 expression in the
MFCDLo was signiﬁcantly lower than the control (p< 0.05,
Figure 5H). On day 21, upregulation of Six6 peaked in the
MFCDs with a signiﬁcant difference between the MFCDLo and
MFCDHi (p< 0.05, Figure 5I). There was no signiﬁcant
difference in the expression of Lhx2 between all three conditions
and they all showed steady increase in expression of this marker
during the 21 day period (Figure 5J).Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Figure 3. A–L) EBs expanded in a similar fashion across all devices during the first 4-5 days of the culture. MFCDLo typically exhibited a monolayer
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www.advancedsciencenews.com www.biotechnology-journal.comVsx2/Chx10 is a transcription marker associated with the
formation of retinal stem cells capable of differentiating into
retinal neurons.[37] It exhibited a rapid increase in expression on
day 5 of differentiation in the MFCD when compared with the
48-well plate control (p< 0.01). The most rapid increase in
expression of Vsx2/Chx10 was observed in the MFCDLo whichBiotechnol. J. 2018, 1800323 1800323 (8 of 13) © 2018 Thewas signiﬁcantly higher than in the MFCDHi (p< 0.01). For the
remainder of culture period, there were no other signiﬁcant
differences in the expression of Vsx2/Chx10 between any
conditions, however further upregulation was evident at
subsequent time points with the exception of the MFCDHi on
day 21 (Figure 5K).Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Figure 4. A) Shows positive expression of Nestin and Otx2 on day 5 of the culture. B) Showing positive expression of the markers Pax6 and Vsx2/Chx10
across all culture devices on day 10. C) Showing positive expression of the retinal precursor markers Crx and Nrl across all culture devices on day 21.
www.advancedsciencenews.com www.biotechnology-journal.comCrx and Nrl have previously been shown to be key markers
of regenerative photoreceptor precursors capable of trans-
locating to the retina and differentiating into functional
photoreceptors upon transplantation into the sub-retinal
space.[1] The expression of Crx was signiﬁcantly higher in the
MFCDs on day 5 when compared to the 48-well plate controls
(p< 0.05). Its expression continued to rise until the end of
the culture period and after 21 days there was signiﬁcantly
more Crx expression in the MFCDHi (p< 0.05). Both MFCDBiotechnol. J. 2018, 1800323 1800323 (9 of 13) © 2018 Theconditions expressed higher levels of Crx than in the 48-well
plate control (Figure 5L). The expression of Nrl peaked at
day 10 and plateaued for the rest of the differentiation in the
control cultures. The highest expression of Nrl (p< 0.01) was
observed in the MFCDLo at day 10. Extended culture in the
MFCD at both ﬂow rates was associated with the down-
regulation of Nrl expression and after 21 days there was
comparable levels of this key transcription factor in all three
cultures (Figure 5M).Authors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
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Figure 5. Shows down-regulation of the pluripotency markers (A) Oct4, (B) Nanog, and (C) Sox2 across the different culture formats. Expression of
different germ layer markers (D) Nestin (ectoderm), (E) Brachyury (mesoderm) and (F) Sox17 (endoderm). EFTFs in (G) Otx2, (H) Pax6, (I) Six6, and (J)
Lhx2. Optic vesicle marker (K) VSx2/Chx10 and retinal precursor markers (L) Crx and (M) Nrl. (N) Shows expression of Rhodopsin. Error bars represent
one SEM about themean of three independent data points (n¼ 3) (p< 0.05; p< 0.01). A repeatedmeasures ANOVA indicated a significant difference
in the expression of each gene between the three conditions. To establish significance between different conditions, a Tukey’s post-test was applied.
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www.advancedsciencenews.com www.biotechnology-journal.comRhodopsin, a receptor protein found on the surface of rod
cells,[38] was used to characterize late stage differentiation in the
MFCDs. At the end of the culture period the expression of
Rhodopsin was very similar in the MFCDHi and the 48-well plate
control. Differentiation under lower ﬂow rates lead to
signiﬁcantly (p< 0.05) lower levels of Rhodopsin expression
indicating that there may be a minimum ﬂow rate needed to
effectively differentiate hiPSCs into mature photoreceptor cells
(Figure 5N). Overview of the average expression of different
markers throughout retinal differentiation of hiPSCs have been
summarized in Figure S2, Supporting Information.4. Discussion
The goal of this study was to establish a process for the retinal
differentiation of hiPSCs in a microﬂuidic cell culture device.
The microﬂuidic culture device had been designed speciﬁcally
for regenerative medicine process development and enabled
greater control over the cellular microenvironment with regards
to shear stress and transport of soluble factors. The MFCD has
previously been used to successfully expand hESCs and
mESCs[33–35] meaning that this was the ﬁrst attempt to
undertake a lengthy directed differentiation process. The
modular design of the MFCD was advantageous for the simple
implementation of stepwise differentiation protocols. The lid
design meant that EBs could be directly seeded into the culture
chamber, thus avoiding the ﬂow through seeding and/or
specialized arrangements for in-situ EB formation. hiPSCs
could be aggregated into EBs using standard techniques (in this
case Aggrewell 400TM) and directly pipetted into the cell culture
chamber. The modular design also allowed for easier and more
efﬁcient collection of cells at the end of the process for qPCR and
immunocytochemistry.
In order to determine the appropriate perfusion rate for
differentiation, a number of considerations were taken into
account. Perfusing at low ﬂow rates can limit the mass transfer
of nutrients and growth factors resulting in the accumulation of
waste products over time. Higher ﬂow rates can introduce shear
stresses and risk of cellular washout. Specially designed ﬂuidics
have been employed to minimize the exposure of attached cells
to excessive shear rates in our MCFD.[33]
In order to determine which growth factors were of greatest
importance to the differentiation process it was necessary to
examine the cellular demands, stability and rates of production/
consumption. The Peclet number calculations for each growth
factor showed that there is a perfusion rate threshold which
allows for convective delivery to be dominant.
Degradation studies revealed that DKK-1 and bFGF degraded
the fastest at 37 C and should be delivered primarily by
convection to the cells. Further investigation of growth factor
production rates during standard cell culture revealed that bFGF
was being produced by the cells meaning that it was not
necessary to supply this factor by convection. Noggin, IGF-1 and
DKK-1 had the highest demand in the ﬁrst 48 h of the culture.
(Figure S1, Supporting Information) IGF-1, being the smallest
molecule of the group, requires a ﬂow rate of more than
650 μL h1 in order to be delivered primarily by convection in the
MFCD. This ﬂow rate would be too high resulting in the otherBiotechnol. J. 2018, 1800323 1800323 (11 of 13) © 2018 Thegrowth factors being forced out of the chamber before they
diffuse sufﬁciently through the medium and have the
opportunity to be delivered to the cells. In addition, IGF-1 is
more resistant to degradation than all the other growth factors
and the functional importance of DKK-1 and Noggin during
photoreceptor differentiation has been conﬁrmed by a second
group.[5] As a result we selected a ﬂow rate of 130 μL h1, which
meant that DKK-1, Noggin and other molecules such as B27 and
N2 supplements, BSA and transferrin were delivered primarily
via convection.
Morphological evaluation of the cultures showed clear
similarities as well as some distinct differences between each
of the cultures. The mean calculated hydrodynamic shear stress
reported in our MFCD was 1.33 104 Pa 0.37 104 Pa at
the height of 10mm above the culture surface at a ﬂow rate of
300mLh1.[33] This rate is three orders of magnitude lower than
what Toh et al.[39] observed in mESCs, 4.5 101 Pa for negative
effects of the shear and an order of magnitude lower than
1.6 103 Pa, for expression of fgf5 in the same cell population,
indicating the effect of shear on the genetic level. For cells to
experience the shear stress of 1.6 103 Pa in our MFCD a ﬂow
rate of 3600mLh1 is required. Whereas, in these experiments,
ﬂow rate of 130mLh1 was used, which was less than half of
what has been reported previously by Reichen et al. Further-
more, no morphological changes were observed during the
course of experiments to indicate any negative effects of the
shear by the cells. However, a more in-depth analysis of the cells
such as expression of fgf5 may reveal the possible effect of shear
at this ﬂow rate.
Differences observed in MFCDLo could have been due to the
Pe/α <1 in this culture. Under these conditions the provision of
growth factors is dominated by diffusion and may result in
depletion over time. Also, accumulating waste molecules would
be removed at a slower rate compared to the control and the
MFCDHi. Morphological observation in the MFCDHi, indicates
possible wash-out of the exogenous molecules that contribute to
the formation of neural rosettes, which were present both in
control culture (48wp) and MFCDLo. Neural rosettes are often
present during the early retinal differentiation of hESCs and
hiPSCs in the presence of IGF-1.[3] IGF-1 has been shown to be
crucial during the formation of retinal progenitors.[40] MFCDHi
also showed a more homogeneous population of the cells and
less formation of the 3D structures, which could have been due
to the higher removal rate of waste molecules or endogenous
signalling factors from the culture area by perfusion. Formation
of the RPE like cells could have been linked to higher expression
of the marker Vsx2/Chx10. It has been reported that Vxs2/Chx10
expression affects expression of themarkerMitf in the RPE cells.
Suppression of the marker Mitf, induces differentiation of optic
vesicle cells toward retinal progenitor cells.[41]
Differences in morphology did not necessarily coincide with
the expression of certain genes in these cultures. Although the
down regulation of pluripotent markers was unaffected, the
perfusion rate had a marked affect upon the expression of germ
layer markers. After 21 days of differentiation MFCDHi was
associated with the highest persistence of mesodermal marker
Brachyury while there was signiﬁcantly more expression of
endoderm marker Sox17 in MFCDLo. Signiﬁcant expression of
the mesodermal and endodermal markers at the late stages ofAuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA
www.advancedsciencenews.com www.biotechnology-journal.comretinal differentiation may have a less signiﬁcant effect on the
homogeneity of the culture. However, since expression of both of
these markers are undesirable for retinal differentiation, further
investigation is required to establish a ﬂow rate/regime that
could mitigate expression of such unwanted markers.
Overall, signiﬁcantly higher expression of Vsx2/Chx10, Crx and
Nrl was observed in both perfused devices on days 5 and 10
compared to the control culture. Retinal progenitors committed to
become photoreceptors express Crx as well as mature photo-
receptors. Expression of Crx indicates higher number of
photoreceptor in the cell population.[42] Nrl expression results
in development of cone photoreceptors.[43] It was reported
previously that post-mitotic precursors that express both Nrl
andCrxhave the highest chance of successful integration intohost
tissue post-transplantation.[1,15] In humans Rhodopsin is
expressed mostly at late stages of photoreceptor maturation
aroundweeks 10–15.[21] Considering 3weeksdifferentiationof the
cells, comparable expression of this marker was observed in
MFCDHi andwell-plate control culture,whichcouldhavebeendue
to its lower expression at this time point. However, differences
between the perfused devices was of note here, indicating the
unfavorable condition at low ﬂow rate cultures for this marker.5. Conclusions
We have demonstrated the longest continuous differentiation of
hiPSCs in a microﬂuidic culture device to date by successfully
maintainingcultures for21days incontinuousperfusion.Executing
long, complex, differentiation processes such as this, in a
microﬂuidic chip, under continuous perfusion is a signiﬁcant
technical advancement. This study represents a signiﬁcant step
forward towards the application of microﬂuidic technology to
pluripotent stemcells in theﬁelds of developmental biology, disease
modelling and regenerative medicine process development.
Measurements for DKK-1 showed that the concentration of this
growth factor must be adapted to the cellular needs during the
course of differentiation. An interesting observationwas the impact
of convective delivery of the key growth factors via perfusion on the
expression of key retinal progenitor markers, Pax6, Vsx2, and Crx
suggesting that ﬂow rate is a key parameter which warrants further
investigation. Optimization of perfusion rate may prove to be an
important operating variable aswemove toward clinical application
androbustprocesseswhich requireﬁnecontrol overdifferentiation.
Degradation, consumption, and endogenous expression of the key
growth factors are vital when deciding the most suitable and cost-
effective protocol for perfused cultures.Supporting Information
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